InvestorsHub Logo

BarrellofHay

04/10/19 3:57 PM

#1051 RE: Klinsmann #1050

I think the issue is valuation. Without a prospectus, its hard to value Ocugen. Funds are not going to come into a company without this data and are likely forbidden to. Once we see a prospectus, we will see heavy movement